We are live on ! Find out more
MRNA icon

Moderna
MRNA

1,140 hedge funds and large institutions have $93.5B invested in Moderna in 2021 Q3 according to their latest regulatory filings, with 322 funds opening new positions, 395 increasing their positions, 325 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

335% more first-time investments, than exits

New positions opened: 322 | Existing positions closed: 74

74% more capital invested

Capital invested by funds: $53.9B → $93.5B (+$39.7B)

26% more funds holding

Funds holding: 903 → 1,140 (+237)

22% more funds holding in top 10

Funds holding in top 10: 32 → 39 (+7)

22% more repeat investments, than reductions

Existing positions increased: 395 | Existing positions reduced: 325

3.19% more ownership

Funds ownership: 57.08% → 60.27% (+3.2%)

13% less call options, than puts

Call options by funds: $8.43B | Put options by funds: $9.72B

Holders
1,140
Holders Change
+237
Holders Change %
+26.25%
% of All Funds
19.96%
Holding in Top 10
39
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+21.88%
% of All Funds
0.68%
New
322
Increased
395
Reduced
325
Closed
74
Calls
$8.43B
Puts
$9.72B
Net Calls
-$1.3B
Net Calls Change
-$577M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.76B
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.58B
3
State Street
State Street
Massachusetts
+$2.45B
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$887M
5
Northern Trust
Northern Trust
Illinois
+$557M

Top Sellers

Rank Fund Capital Flow
1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
-$1.35B
2
FP
Flagship Pioneering
Massachusetts
-$1.11B
3
TP
Theleme Partners
United Kingdom
-$780M
4
Morgan Stanley
Morgan Stanley
New York
-$649M
5
Renaissance Technologies
Renaissance Technologies
New York
-$438M
Name Holding Trade Value Shares
Change 		Change in
Stake
ICG
1151
InterOcean Capital Group
Tennessee
– -$2.35M -10,000 Closed
PMAM
1152
Picton Mahoney Asset Management
Ontario, Canada
– -$2.33M -9,921 Closed
PG
1153
Pendal Group
Australia
– -$1.93M -8,210 Closed
LSAG
1154
Lake Street Advisors Group
New Hampshire
– -$3.07M -7,841 Closed
B
1155
BP
United Kingdom
– -$1.71M -7,269 Closed
TCM
1156
Tuttle Capital Management
Connecticut
– -$1.3M -5,535 Closed
ACM
1157
ACT Capital Management
Pennsylvania
– -$1.06M -4,500 Closed
AI
1158
AXS Investments
New York
– -$900K -3,830 Closed
PGAM
1159
Princeton Global Asset Management
New Jersey
– -$880K -3,744 Closed
IC
1160
Inscription Capital
Texas
– -$854K -3,635 Closed
AIL
1161
AGF Investments LLC
Ontario, Canada
– -$851K -3,621 Closed
QT
1162
Quantbot Technologies
New York
– -$787K -3,352 Closed
Walleye Capital
1163
Walleye Capital
New York
– -$759 -3,232 Closed
CGIM
1164
Cannon Global Investment Management
Florida
– -$728K -3,100 Closed
CC
1165
Claybrook Capital
Massachusetts
– -$705K -3,002 Closed
QTM
1166
qPULA Trading Management
New York
– -$689K -2,933 Closed
CFA
1167
Capstone Financial Advisors
Illinois
– -$655K -2,788 Closed
GA
1168
Gateway Advisory
New Jersey
– -$538K -2,290 Closed
LOAMS
1169
Lombard Odier Asset Management (Switzerland)
Switzerland
– -$508K -2,164 Closed
SEC
1170
Seven Eight Capital
New York
– -$487K -2,072 Closed
ARC
1171
Advisor Resource Council
Texas
– -$468K -1,993 Closed
TCM
1172
Teza Capital Management
Illinois
– -$443K -1,887 Closed
G
1173
Gainplan
Michigan
– -$403K -1,693 Closed
SFS
1174
Strategic Financial Services
New York
– -$395K -1,680 Closed
BFM
1175
Boothbay Fund Management
New York
– -$336K -1,432 Closed
45 46
47
48 49

MRNA Hedge Fund Activity: Q3 2021 in Review

1,140 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q3 2021, worth a combined $93.5B — up 74% from $53.9B a quarter earlier.

Buyers outnumbered sellers: 322 funds opened new MRNA positions and 74 closed out — a net gain of 248 holders — while 395 added to existing stakes and 325 trimmed.

The largest buyer was BlackRock, adding an estimated $2.76B. The largest seller was Baillie Gifford & Co, cutting an estimated $1.35B.

  • 1,140 institutional investors held Moderna (MRNA) as of Q3 2021, up from 903 in Q2 2021.
  • Funds reported $93.5B of Moderna stock for Q3 2021, up 74% quarter-over-quarter.
  • 322 funds opened new Moderna positions in Q3 2021 and 74 closed out, a net change of +248 holders.
  • The largest Moderna buyer in Q3 2021 was BlackRock, an estimated $2.76B added.
  • The largest Moderna seller in Q3 2021 was Baillie Gifford & Co, an estimated $1.35B sold.

Based on aggregated 13F filings for Q3 2021.